FDA Approved: MIGLUSTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for miglustat (MIGLUSTAT) under ANDA 208342.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• Miglustat (miglustat)

Snippet

SUPPL AP for MIGLUSTAT (MIGLUSTAT)